supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
drug:
Vorinostat
supplement:
Adrenocorticotropic Hormone
Research Papers that Mention the Interaction
“Lastly, we confirmed that SAHA (1 µM/24 h) decreased hCtT survival (78.92%; P = 0.0007) and ACTH secretion (83.64%; P = 0.03).”
Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease“ Vorinostat (1 µM/3-24 hours) resulted in significant reduction (70%, P < .001) of secreted ACTH in media.”
213 Histone Deacetylase Inhibitor Vorinostat Is a Novel, Promising Treatment for Cushing Disease.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback